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Editor’s Choice
Section Editor
Robert C. Griggs, MD
Editors’ Note: In WriteClick this week, Drs. Finke and Pru¨ss
comment on influenza-associated encephalitis (IAE) as
discussed in “Clinical Reasoning: A 57-year-old woman who
developed acute amnesia following fever and upper respiratory
symptoms,” and suggest patients with suspected IAE be tested
for neuronal antibodies. In reference to “Spatial cluster analysis
of population amyotrophic lateral sclerosis risk in Ireland,” Drs.
Bradley et al. and authors Rooney et al., who have published
further work, discuss methodologic considerations in testing for
amyotrophic lateral sclerosis clusters.
—Megan Alcauskas, MD, and Robert C. Griggs, MD
CLINICAL REASONING: A 57-YEAR-OLD WOMAN
WHO DEVELOPED ACUTE AMNESIA FOLLOWING
FEVER AND UPPER RESPIRATORY SYMPTOMS
Carsten Finke, Harald Prüss, Berlin: McCray et al.1
described a patient with an influenza-associated
encephalitis (IAE). As they stated, IAE is believed
to be caused by an immune-mediated mechanism
rather than direct viral toxicity. Their patient did
not respond to antiviral therapy but improved after
immunomodulatory treatment with steroids and
immunoglobulins.
The recent discovery of antibodies to neuronal
surface proteins has revolutionized clinical neurol-
ogy and has led to the identification of several new
autoimmune encephalitides. A viral trigger has been
considered in many of these conditions and has been
demonstrated for herpes simplex virus type I and
varicella-zoster virus, both of which can trigger
anti–NMDA receptor (NMDAR) encephalitis.2,3
Moreover, a past influenza A infection can predispose
to the development of serum NMDAR antibodies,4
and positive influenza serology is common in acute
NMDAR encephalitis.5 In contrast to the authors’
notion, autoimmune encephalitides can occur with
rapid onset and acute deterioration as well as with nor-
mal CSF leukocyte count.
Perhaps patients with suspected IAE should be
tested for neuronal antibodies using cell-based and
CNS tissue assays to rule out antibody-mediated
autoimmune encephalitis. In addition, this testing
would further our understanding of parainfectious
autoimmune encephalitides.
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SPATIAL CLUSTER ANALYSIS OF POPULATION
AMYOTROPHIC LATERAL SCLEROSIS RISK IN
IRELAND
Walter G. Bradley, Palmetto Bay, FL; Elijah W.
Stommel, Xun Shi, Hanover; Nathan M. Torbick,
Newmarket; Tracie A. Caller, Hanover, NH; Clive
E. Sabel, Bristol, UK: We read with interest the
article by Rooney et al.,1 who reported no significant
high-risk clusters of patients with amyotrophic lateral
sclerosis (ALS) in the Irish ALS Register. They referred
to reports, including our own, of statistically increased
frequency of ALS in Finland, northern New England,
and France.2–4 Methodologic, conceptual, and real dif-
ferences between risk factors in one region and another
may explain the differences between studies. If cases are
aggregated over large areas, the effect of a localized toxic
exposure may be lost.
Sabel et al.4 and Wheeler5 showed that the kernel
density function method revealed statistically signif-
icant areas of increased risk for ALS in Finland and
leukemia in Ohio that were not detected with SaTS-
can and other methods. Our studies of ALS clusters
in northern New England originated from recogni-
tion of a cluster of patients with ALS who lived near
Lake Mascoma in New Hampshire, which has fre-
quent cyanobacteria blooms. We found 11 clusters
of statistically significant high incidence in northern
New England, supporting our hypothesis that living
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near water bodies with cyanobacteria blooms was a
risk factor for ALS.3
It is likely that sporadic ALS is a multifactorial dis-
ease, resulting from the interaction of multiple environ-
mental risk factors with multiple genetic predisposing
factors. Therefore, studies of regional distribution of
cases and of underlying genetic factors may fail if they
do not focus on individual risk factors.
Author Response: James P. Rooney, Anthony
Staines, Orla Hardiman, Dublin:We thank Bradley
et al. for their interest and comments on our article.1
We agree that “If cases are aggregated over large areas,
the effect of a localized toxic exposure may be lost.”
Therefore, we have undertaken a new study where we
replicated our analysis at a higher spatial resolution of
over 18,000 small areas consisting of no more than
200 residences each.6
We also agree that “sporadic ALS is a multifacto-
rial disease, resulting from the interaction of multiple
environmental risk factors with multiple genetic pre-
disposing factors.” There is recent epidemiologic evi-
dence for this in the form of multistep models for
ALS.7 We are also cognizant of the ecological fallacy
(i.e., inappropriately ascribing group-level correla-
tions to individual-level variables), and agree that
individual risk factors are important to include in
models wherever possible.
However, our study did report positive results. Our
methods were sensitive enough to find 2 statistically
significant low-risk areas, as well as detect 5 cases that
presented late and 2 that presented cross-border. The
algorithms used are agnostic to hot or cold spots; there-
fore, if hot spots did exist, we are confident we would
have detected them.
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CORRECTION
CNS neutrophilic vasculitis in neuro-Sweet disease
In the Clinical/Scientific Note “CNS neutrophilic vasculitis in neuro-Sweet disease” by R. Charlson et al. (Neurology®
2015;85:829–830), there is an error in the discussion and the references. The last name of the first author of reference 2
should be Hisanaga, not Hisanga as originally published. The authors regret the error.
Author disclosures are available upon request (journal@neurology.org).
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